Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 5;16(1):37.
doi: 10.1186/s11689-024-09552-x.

An integrated clinical approach to children at genetic risk for neurodevelopmental and psychiatric conditions: interdisciplinary collaboration and research infrastructure

Affiliations

An integrated clinical approach to children at genetic risk for neurodevelopmental and psychiatric conditions: interdisciplinary collaboration and research infrastructure

Jane Summers et al. J Neurodev Disord. .

Abstract

Background: A sizeable proportion of pathogenic genetic variants identified in young children tested for congenital differences are associated with neurodevelopmental psychiatric disorders (NPD). In this growing group, a genetic diagnosis often precedes the emergence of diagnosable developmental concerns. Here, we describe DAGSY (Developmental Assessment of Genetically Susceptible Youth), a novel interdisciplinary 'genetic-diagnosis-first' clinic integrating psychiatric, psychological and genetic expertise, and report our first observations and feedback from families and referring clinicians.

Methods: We retrieved data on referral sources and indications, genetic and NPD diagnoses and recommendations for children seen at DAGSY between 2018 and 2022. Through a survey, we obtained feedback from twenty families and eleven referring clinicians.

Results: 159 children (mean age 10.2 years, 57.2% males) completed an interdisciplinary (psychiatry, psychology, genetic counselling) DAGSY assessment during this period. Of these, 69.8% had a pathogenic microdeletion or microduplication, 21.5% a sequence-level variant, 4.4% a chromosomal disorder, and 4.4% a variant of unknown significance with emerging evidence of pathogenicity. One in four children did not have a prior NPD diagnosis, and referral to DAGSY was motivated by their genetic vulnerability alone. Following assessment, 76.7% received at least one new NPD diagnosis, most frequently intellectual disability (24.5%), anxiety (20.7%), autism spectrum (18.9%) and specific learning (16.4%) disorder. Both families and clinicians responding to our survey expressed satisfaction, but also highlighted some areas for potential improvement.

Conclusions: DAGSY addresses an unmet clinical need for children identified with genetic variants that confer increased vulnerability for NPD and provides a crucial platform for research in this area. DAGSY can serve as a model for interdisciplinary clinics integrating child psychiatry, psychology and genetics, addressing both clinical and research needs for this emerging population.

Keywords: Genetic disorder; Genetics; Interdisciplinary clinic; Mental health; Neurodevelopmental disorder; Psychiatry; Psychology; Research framework.

PubMed Disclaimer

Conflict of interest statement

J.V. has served as a consultant for NoBias Therapeutics Inc. and has received speaker fees for Henry Stewart Talks Ltd. S.W.S. is on the Scientific Advisory Committee of Population Bio, Deep Genomics, and serves as a Highly Cited Academic Advisor for King Abdulaziz University. Intellectual property from aspects of his research held at The Hospital for Sick Children are licensed to Athena Diagnostics and Population Bio. D.B. has received research funding from MapLight therapeutics. These relationships did not influence content of this manuscript but are disclosed for potential future considerations.

Figures

Fig. 1
Fig. 1
(a) Overview of DAGSY referral flow. (b) Assessment procedure for DAGSY *Feedback appointment initially in person, during pandemic exclusively online, currently offered in both modalities to families
Fig. 2
Fig. 2
Pre-existing and new NPD diagnoses prior to and following DAGSY assessment This figure shows the proportion of children per NPD diagnosis count (including developmental delay as a diagnosis), calculated for three age groups. The proportion of children without a pre-existing NPD diagnosis is highest in the youngest age group, whereas in the older age groups the proportion of children with multiple NPD diagnoses increases, indicative of an accumulation of diagnoses over time in this population
Fig. 3
Fig. 3
Survey results

Similar articles

Cited by

References

    1. Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG) Genet Med. 2021;23(11):2029–37. doi: 10.1038/s41436-021-01242-6. - DOI - PubMed
    1. Srivastava S, Love-Nichols JA, Dies KA, Ledbetter DH, Martin CL, Chung WK, et al. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med. 2019;21(11):2413–21. doi: 10.1038/s41436-019-0554-6. - DOI - PMC - PubMed
    1. Costain G, Walker S, Marano M, Veenma D, Snell M, Curtis M, et al. Genome sequencing as a diagnostic test in Children with Unexplained Medical Complexity. JAMA Netw Open. 2020;3(9):e2018109. doi: 10.1001/jamanetworkopen.2020.18109. - DOI - PMC - PubMed
    1. Oei K, Hayeems RZ, Ungar WJ, Cohn RD, Cohen E. Genetic testing among children in a Complex Care Program. Child Basel Switz. 2017;4(5):42. - PMC - PubMed
    1. Lee PH, Feng YCA, Smoller JW. Pleiotropy and Cross-disorder Genetics among Psychiatric disorders. Biol Psychiatry. 2021;89(1):20–31. doi: 10.1016/j.biopsych.2020.09.026. - DOI - PMC - PubMed